Functional MRI shows cognitive rehab aiding mildly impaired elderly minds

The cognitive therapy called Attention Process Training-II (APT-II) provides worthwhile benefits to elderly patients with mild cognitive impairment (MCI) who have cerebral small vessel disease and are therefore at heightened risk for dementia.

In the Italian study behind the finding, the effects of the neuropsychological intervention showed up as improvements in focused attention and working memory, as well as increased brain activity observable on functional MRI.

The Journal of Alzheimer’s Disease published the research online Aug. 30.

Leonardo Pantoni, MD, PhD, of the University of Florence and colleagues randomized 43 MCI patients with cerebral small vessel disease into either APT-II (“treated”) or standard care (“untreated”) groups.

The patients were imaged with resting-state fMRI, and evaluated for function and quality of life, first at baseline and then at six and 12 months post-intervention.

The researchers observed no significant difference between the treated and untreated patients on measures of functional status and quality of life.

However, an auditory-verbal test checking immediate recall brought back a significant improvement in the treated group only, and the same held for a visual search test.

Meanwhile, the resting-state fMRI showed significantly greater synchronization of activity in cerebellar areas between baseline and follow-up in the treated group.

In the untreated group, such syncing did not occur.

Journal publisher IOS Press has posted the study in full for free.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.